PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

60 million doses of COVID-19 vaccine administered in UK

Health services across the UK have now administered a total of around 60.6 million vaccines since 8 December, including around 37.9 million people with their first d...
Continue Reading →
News

Experts state contract services sector the big winner of pandemic at CPhI Discover

Near-term capacity constraints for recombinant vector manufacturing, with continuous bioprocessing & process intensification set for rapid growth in next 5-10 ye...
Continue Reading →
News

Pandemic coincided with increase in mental health problems for children

New research has found an association between the COVID-19 pandemic and a ‘sharp’ increase in mental health issues for children aged 11 to 12 years old. The study, c...
Continue Reading →
News

Merck extends oncology and autoimmunity collaboration with BioMed X

Merck has extended its existing collaboration with BioMed X, an independent research institute located at the University of Heidelberg in Germany, to continue resear...
Continue Reading →
News

Novo Nordisk’s ziltivekimab hits primary endpoint in CKD trial

Novo Nordisk’s investigational interleukin-6 (IL-6) inhibitor ziltivekimab met the primary endpoint in a Phase II trial in people with advanced chronic kidney diseas...
Continue Reading →
News

Sanofi and GSK COVID-19 vaccine candidate demonstrates positive Phase II results

The Sanofi and GlaxoSmithKline (GSK) COVID-19 vaccine candidate has achieved positive results in all adult age groups in a Phase II study with 722 volunteers. A glob...
Continue Reading →
News

Medicago and GSK’s plant-derived COVID-19 vaccine achieves positive trial results

Medicago and GlaxoSmithKline (GSK) have reported positive interim Phase II clinical trial safety and immunogenicity data for Medicago’s plant-derived COVID-19 vaccin...
Continue Reading →
CPhI Discover: in the future pharma companies will need to work closer with excipient companies if we are to develop better formulations and faster
News

CPhI Discover: in the future pharma companies will need to work closer with excipient companies if we are to develop better formulations and faster

In this Q&A article with Dr Iain Moore, President of EXCiPACT – ahead of his keynote session at CPhI Discover (17th-28th May 2021), global pharma’s largest e...
Continue Reading →
News

Phico Therapeutics raises £7m to advance next-gen antibiotic candidate

Cambridge, UK-based biotech company Phico Therapeutics has announced new investments of £7m, led by the UK’s most active growth capital investor BGF. The new investm...
Continue Reading →
News

Novavax Announces positive preclinical data for combination influenza and COVID-19 vaccine candidate

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data from a preclinical st...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026